Skip to main content

The danger in saying yes to Pascal Soriot’s pay rise at AstraZeneca | Nils Prately

Despite rebellion, approval of £18.7m package opens door to likelihood of US-style executive pay elsewhere

Is Pascal Soriot, the chief executive of AstraZeneca, “massively underpaid”, as the chief investment officer of Florida-based GQG Partners, one of the company’s big shareholders, argued this week? Well, of course he’s not. Soriot has been paid £120m over the past decade, which is a helluva sum even for someone who has been brilliantly successful in leading what is now – but wasn’t when he arrived – the UK’s second-largest listed company.

The history-turning moment in 2014, when AZ and Soriot managed to see off a bid from Pfizer’s grim number-crunchers, has probably been worth many multiples of £120m to the UK economy. But such a sum for a single employee in an organisation of 90,000 still looks absurd: Soriot doesn’t do all the work himself.

Continue reading...

from The Guardian https://ift.tt/V2FnCkM

Comments

Popular posts from this blog

The Guardian view on Covid-19, five years on: lessons still to be learned | Editorial

Though many would rather forget the pandemic, we are living with its consequences. Are we any better prepared for the next one? “When asked what was the biggest disaster of the twentieth century, almost nobody answers the Spanish flu,” notes Laura Spinney in her book Pale Rider, of an event that killed as many as one in 20 of the global population. “There is no cenotaph, no monument in London, Moscow or Washington DC.” Most of us will better understand that absence after Covid-19 , which was declared a pandemic by the World Health Organization five years ago this week. Some cannot put those events behind them: most obviously, many of those bereaved by the 7 million deaths worldwide (not including those indirectly caused by the pandemic ), and the significant numbers still living with long Covid . Others want to forget the loss of loved ones, the months of isolation and the costs to businesses, families and mental health. Do you have an opinion on the issues raised in this article? I...